COVID-19 Antibodies and Outcomes among Outpatient Maintenance Hemodialysis Patients.

Background Patients on maintenance hemodialysis are particularly vulnerable to infection and hospitalization from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to immunocompromised patients and the clustering that occurs in outpatient dialysis units, the seroprevalence of COVID-19 antibodies in this population is unknown and has significant implications for public health. Also, little is known about their risk factors for hospitalization. Methods Three outpatient maintenance hemodialysis units affiliated with a major teaching hospital in the New York area were studied. We determined rates of SARS-CoV-2 positivity via nasopharyngeal, real-time, reverse-transcriptase PCR (RT-PCR); SARS-CoV-2 IgG seropositivity; hospitalization; and mortality. Results Of 367 patients, 28% had either SARS-CoV-2 seropositivity or PCR positivity. Prevalence across the three respective units was 7%, 32%, and 70%. Those who were either antibody or PCR positive were significantly younger (65 versus 69 years, P=0.05), and had a higher prevalence of Black race (43% versus 30%, P=0.001) and Hispanic ethnicity (32% versus 12%, P<0.001) compared with those who tested negative. Higher positivity rates were also observed among those who took taxis and ambulettes to and from dialysis, compared with those who used personal transportation. Antibodies were detected in all of the patients with a positive PCR result who underwent serologic testing. Of those that were seropositive, 32% were asymptomatic. The hospitalization rate on the basis of either antibody or PCR positivity was 35%, with a hospital mortality rate of 33%. Aside from COPD, no other variables were more prevalent in patients who were hospitalized. Conclusions We observed significant differences in rates of COVID-19 infection within three outpatient dialysis units, with universal seroconversion. Among patients with ESKD, rates of asymptomatic infection appear to be high, as do hospitalization and mortality rates.

[1]  P. Karaca-Mandic,et al.  Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States. , 2020, JAMA internal medicine.

[2]  P. Kelleher,et al.  High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. , 2020, Journal of the American Society of Nephrology : JASN.

[3]  Otto O. Yang,et al.  Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 , 2020, The New England journal of medicine.

[4]  Jing Huang,et al.  Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China , 2020, American Journal of Kidney Diseases.

[5]  A. Dunn,et al.  Risk Factors for Mortality in Patients with COVID-19 in New York City , 2020, Journal of General Internal Medicine.

[6]  H. V. Bakel,et al.  Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City , 2020, medRxiv.

[7]  D. Nitsch,et al.  Epidemiology of COVID-19 in an Urban Dialysis Center. , 2020, Journal of the American Society of Nephrology : JASN.

[8]  X. Tang,et al.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.

[9]  Lei Liu,et al.  Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients , 2020, Kidney International Reports.

[10]  Steven Woloshin,et al.  False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. , 2020, The New England journal of medicine.

[11]  A. Gharavi,et al.  Presentation and Outcomes of Patients with ESKD and COVID-19. , 2020, Journal of the American Society of Nephrology : JASN.

[12]  Shouzhi Fu,et al.  Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[13]  A. Carroll,et al.  Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. , 2020, JAMA.

[14]  Hui Tang,et al.  Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. , 2020, Journal of the American Society of Nephrology : JASN.

[15]  F. Scolari,et al.  A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection , 2020, Kidney International.

[16]  C. Hemsley,et al.  De-isolation of COVID-19–positive hemodialysis patients in the outpatient setting: a single-center experience , 2020, Kidney International.

[17]  M. Wener,et al.  Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho , 2020, Journal of Clinical Microbiology.

[18]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[19]  T. Rea,et al.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.

[20]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[21]  Xiao-Neng Mo,et al.  Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients , 2020, Emerging microbes & infections.

[22]  A. Garg,et al.  Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.

[23]  B. Jaber,et al.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. , 2000, Kidney international.